Effect of Rituximab Compared with Natalizumab and Fingolimod in Patients with Relapsing–Remitting Multiple Sclerosis: A Cohort Study by Martha Rocio Hernández-Preciado, Jazmin Marquez-Pedroza, Nayeli Alejandra Sánchez-Rosales, José de Jesús García-Rivera, Antonio Kobayashi-Gutiérrez, Blanca Miriam Torres-Mendoza, Efraín Chavarría-Avila, Raúl Alejandro Montaño-Serrano, Fernando Cortes-Enriquez, Mario Alberto Mireles-Ramírez

Get full text